BerGenBio ASA (FRA:7BG0) Other Operating Expense : €5.55 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BerGenBio ASA Other Operating Expense?

BerGenBio ASA's Other Operating Expense for the three months ended in Dec. 2024 was €1.01 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €5.55 Mil.

BerGenBio ASA's quarterly Other Operating Expense declined from Jun. 2024 (€1.64 Mil) to Sep. 2024 (€1.33 Mil) and declined from Sep. 2024 (€1.33 Mil) to Dec. 2024 (€1.01 Mil).

BerGenBio ASA's annual Other Operating Expense declined from Dec. 2022 (€9.90 Mil) to Dec. 2023 (€7.34 Mil) and declined from Dec. 2023 (€7.34 Mil) to Dec. 2024 (€5.48 Mil).

BerGenBio ASA Other Operating Expense Historical Data

The historical data trend for BerGenBio ASA's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Other Operating Expense Chart

BerGenBio ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

7.22

10.78

9.90

7.34

5.48

BerGenBio ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															1.26	1.56	1.64	1.33	1.01

BerGenBio ASA Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.55 Mil.

BerGenBio ASA Other Operating Expense Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (FRA:7BG0) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

BGBIO:Norway 0RU5:UK

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.

BerGenBio ASA Headlines

No Headlines